Global Cannabis Drug Market Research Report 2024(Status and Outlook)
Report Overview
Cannabis, commonly known as marijuana, is a plant-based drug derived from the Cannabis sativa plant. It contains psychoactive compounds such as THC and CBD, which have various medicinal and recreational uses. The market for cannabis products has seen significant growth in recent years due to changing regulations, increased acceptance of its medicinal properties, and shifting consumer attitudes.
The current market size for cannabis drugs in 2023 is estimated at approximately USD 20 million. The market is projected to grow at a Compound Annual Growth Rate (CAGR) of 15.75% from 2024 to 2032, reaching a value of USD 65 million by the end of the forecast period. This growth can be attributed to several key drivers and market forces.
One of the primary growth drivers for the cannabis drug market is the increasing legalization of cannabis for medical and recreational use in various regions globally. Countries like Canada, parts of the United States, and several European nations have legalized cannabis, leading to a surge in demand for cannabis-based products. Additionally, growing awareness about the therapeutic benefits of cannabis in treating conditions such as chronic pain, epilepsy, and anxiety is driving market growth.
Another significant factor fueling market expansion is the rising investments in research and development of cannabis-based pharmaceuticals. Pharmaceutical companies are increasingly exploring the potential of cannabis-derived compounds for developing new drugs to address a wide range of health issues. This research-driven approach is expected to drive innovation and product development in the cannabis drug market.
In terms of market trends, there is a growing shift towards the use of CBD (cannabidiol) products for health and wellness purposes. CBD, a non-psychoactive compound found in cannabis, is gaining popularity for its potential therapeutic effects without the 'high' associated with THC. Products such as CBD oils, edibles, and topicals are witnessing strong demand among consumers seeking natural remedies for various health conditions.
Moreover, the market is witnessing a trend towards product diversification and premiumization. Cannabis companies are introducing a wide range of products, including concentrates, extracts, and infused beverages, to cater to different consumer preferences. Additionally, there is a growing focus on quality and branding to differentiate products in a competitive market landscape.
From a regional perspective, North America is currently the leading market for cannabis drugs, driven by the legalization of recreational cannabis in Canada and several U.S. states. The region's dominance can be attributed to favorable regulatory environments, increasing consumer acceptance, and a well-established cannabis industry infrastructure. In contrast, regions like Europe and Asia-Pacific are experiencing gradual market growth due to evolving regulations and cultural attitudes towards cannabis.
Despite the promising growth prospects, the cannabis drug market faces several challenges. These include regulatory uncertainties, quality control issues, supply chain disruptions, and stigma associated with cannabis use. Addressing these challenges will be crucial for sustaining the market's growth trajectory and unlocking its full potential in the coming years.
In conclusion, the cannabis drug market is poised for significant growth driven by legalization trends, research advancements, shifting consumer preferences, and product innovation. Understanding and navigating the market trends, regional dynamics, and key challenges will be essential for stakeholders to capitalize on the opportunities presented by the evolving cannabis industry landscape.
This report provides a deep insight into the global Cannabis Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cannabis Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cannabis Drug market in any manner.
Global Cannabis Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Greenwich Biosciences
Abbive
Insys Therapeutics
Bausch Health
GW Pharmaceuticals
Unimed Pharmaceuticals
Indevus Pharmaceuticals
Pharmos
Market Segmentation (by Type)
Oral Spray
Capsule
Tablets
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cannabis Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Cannabis, commonly known as marijuana, is a plant-based drug derived from the Cannabis sativa plant. It contains psychoactive compounds such as THC and CBD, which have various medicinal and recreational uses. The market for cannabis products has seen significant growth in recent years due to changing regulations, increased acceptance of its medicinal properties, and shifting consumer attitudes.
The current market size for cannabis drugs in 2023 is estimated at approximately USD 20 million. The market is projected to grow at a Compound Annual Growth Rate (CAGR) of 15.75% from 2024 to 2032, reaching a value of USD 65 million by the end of the forecast period. This growth can be attributed to several key drivers and market forces.
One of the primary growth drivers for the cannabis drug market is the increasing legalization of cannabis for medical and recreational use in various regions globally. Countries like Canada, parts of the United States, and several European nations have legalized cannabis, leading to a surge in demand for cannabis-based products. Additionally, growing awareness about the therapeutic benefits of cannabis in treating conditions such as chronic pain, epilepsy, and anxiety is driving market growth.
Another significant factor fueling market expansion is the rising investments in research and development of cannabis-based pharmaceuticals. Pharmaceutical companies are increasingly exploring the potential of cannabis-derived compounds for developing new drugs to address a wide range of health issues. This research-driven approach is expected to drive innovation and product development in the cannabis drug market.
In terms of market trends, there is a growing shift towards the use of CBD (cannabidiol) products for health and wellness purposes. CBD, a non-psychoactive compound found in cannabis, is gaining popularity for its potential therapeutic effects without the 'high' associated with THC. Products such as CBD oils, edibles, and topicals are witnessing strong demand among consumers seeking natural remedies for various health conditions.
Moreover, the market is witnessing a trend towards product diversification and premiumization. Cannabis companies are introducing a wide range of products, including concentrates, extracts, and infused beverages, to cater to different consumer preferences. Additionally, there is a growing focus on quality and branding to differentiate products in a competitive market landscape.
From a regional perspective, North America is currently the leading market for cannabis drugs, driven by the legalization of recreational cannabis in Canada and several U.S. states. The region's dominance can be attributed to favorable regulatory environments, increasing consumer acceptance, and a well-established cannabis industry infrastructure. In contrast, regions like Europe and Asia-Pacific are experiencing gradual market growth due to evolving regulations and cultural attitudes towards cannabis.
Despite the promising growth prospects, the cannabis drug market faces several challenges. These include regulatory uncertainties, quality control issues, supply chain disruptions, and stigma associated with cannabis use. Addressing these challenges will be crucial for sustaining the market's growth trajectory and unlocking its full potential in the coming years.
In conclusion, the cannabis drug market is poised for significant growth driven by legalization trends, research advancements, shifting consumer preferences, and product innovation. Understanding and navigating the market trends, regional dynamics, and key challenges will be essential for stakeholders to capitalize on the opportunities presented by the evolving cannabis industry landscape.
This report provides a deep insight into the global Cannabis Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cannabis Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cannabis Drug market in any manner.
Global Cannabis Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Greenwich Biosciences
Abbive
Insys Therapeutics
Bausch Health
GW Pharmaceuticals
Unimed Pharmaceuticals
Indevus Pharmaceuticals
Pharmos
Market Segmentation (by Type)
Oral Spray
Capsule
Tablets
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Cannabis Drug Market
- Overview of the regional outlook of the Cannabis Drug Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cannabis Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Cannabis Drug
1.2 Key Market Segments
1.2.1 Cannabis Drug Segment by Type
1.2.2 Cannabis Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CANNABIS DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cannabis Drug Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Cannabis Drug Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
2.4 Macroeconomic Analysis
3 CANNABIS DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Cannabis Drug Sales by Manufacturers (2019-2024)
3.2 Global Cannabis Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Cannabis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cannabis Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cannabis Drug Sales Sites, Area Served, Product Type
3.6 Cannabis Drug Market Competitive Situation and Trends
3.6.1 Cannabis Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cannabis Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CANNABIS DRUG INDUSTRY CHAIN ANALYSIS
4.1 Cannabis Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CANNABIS DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CANNABIS DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cannabis Drug Sales Market Share by Type (2019-2024)
6.3 Global Cannabis Drug Market Size Market Share by Type (2019-2024)
6.4 Global Cannabis Drug Price by Type (2019-2024)
7 CANNABIS DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cannabis Drug Market Sales by Application (2019-2024)
7.3 Global Cannabis Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Cannabis Drug Sales Growth Rate by Application (2019-2024)
8 CANNABIS DRUG MARKET SALES BY REGION
8.1 Global Cannabis Drug Sales by Region
8.1.1 Global Cannabis Drug Sales by Region
8.1.2 Global Cannabis Drug Sales Market Share by Region
8.2 Global Cannabis Drug Market Size by Region
8.2.1 Global Cannabis Drug Market Size by Region
8.2.2 Global Cannabis Drug Market Size Market Share by Region
8.3 North America
8.3.1 North America Cannabis Drug Sales by Country
8.3.2 North America Cannabis Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Cannabis Drug Sales by Country
8.4.2 Europe Cannabis Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Russia Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Cannabis Drug Sales by Region
8.5.2 China
8.5.3 Japan
8.5.4 South Korea
8.5.5 India
8.5.6 Southeast Asia
8.6 Asia Pacific
8.6.1 Asia Pacific Cannabis Drug Market Size by Region
8.6.2 Asia Pacific Cannabis Drug Market Size by Region
8.6.3 China
8.6.4 Japan
8.6.5 South Korea
8.6.6 India
8.6.7 Southeast Asia
8.7 South America
8.7.1 South America Cannabis Drug Sales by Country
8.7.2 South America Cannabis Drug Market Size by Country
8.7.3 Brazil
8.7.4 Argentina
8.7.5 Columbia
8.8 Middle East and Africa
8.8.1 Middle East and Africa Cannabis Drug Sales by Region
8.8.2 Middle East and Africa Cannabis Drug Market Size by Region
8.8.3 Saudi Arabia
8.8.4 UAE
8.8.5 Egypt
8.8.6 Nigeria
8.8.7 South Africa
9 CANNABIS DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Cannabis Drug by Region (2019-2024)
9.2 Global Cannabis Drug Revenue Market Share by Region (2019-2024)
9.3 Global Cannabis Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Cannabis Drug Production
9.4.1 North America Cannabis Drug Production Growth Rate (2019-2024)
9.4.2 North America Cannabis Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Cannabis Drug Production
9.5.1 Europe Cannabis Drug Production Growth Rate (2019-2024)
9.5.2 Europe Cannabis Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Cannabis Drug Production (2019-2024)
9.6.1 Japan Cannabis Drug Production Growth Rate (2019-2024)
9.6.2 Japan Cannabis Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Cannabis Drug Production (2019-2024)
9.7.1 China Cannabis Drug Production Growth Rate (2019-2024)
9.7.2 China Cannabis Drug Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Greenwich Biosciences
10.1.1 Greenwich Biosciences Cannabis Drug Basic Information
10.1.2 Greenwich Biosciences Cannabis Drug Product Overview
10.1.3 Greenwich Biosciences Cannabis Drug Product Market Performance
10.1.4 Greenwich Biosciences Business Overview
10.1.5 Greenwich Biosciences Cannabis Drug SWOT Analysis
10.1.6 Greenwich Biosciences Recent Developments
10.2 Abbive
10.2.1 Abbive Cannabis Drug Basic Information
10.2.2 Abbive Cannabis Drug Product Overview
10.2.3 Abbive Cannabis Drug Product Market Performance
10.2.4 Abbive Business Overview
10.2.5 Abbive Cannabis Drug SWOT Analysis
10.2.6 Abbive Recent Developments
10.3 Insys Therapeutics
10.3.1 Insys Therapeutics Cannabis Drug Basic Information
10.3.2 Insys Therapeutics Cannabis Drug Product Overview
10.3.3 Insys Therapeutics Cannabis Drug Product Market Performance
10.3.4 Insys Therapeutics Cannabis Drug SWOT Analysis
10.3.5 Insys Therapeutics Business Overview
10.3.6 Insys Therapeutics Recent Developments
10.4 Bausch Health
10.4.1 Bausch Health Cannabis Drug Basic Information
10.4.2 Bausch Health Cannabis Drug Product Overview
10.4.3 Bausch Health Cannabis Drug Product Market Performance
10.4.4 Bausch Health Business Overview
10.4.5 Bausch Health Recent Developments
10.5 GW Pharmaceuticals
10.5.1 GW Pharmaceuticals Cannabis Drug Basic Information
10.5.2 GW Pharmaceuticals Cannabis Drug Product Overview
10.5.3 GW Pharmaceuticals Cannabis Drug Product Market Performance
10.5.4 GW Pharmaceuticals Business Overview
10.5.5 GW Pharmaceuticals Recent Developments
10.6 Unimed Pharmaceuticals
10.6.1 Unimed Pharmaceuticals Cannabis Drug Basic Information
10.6.2 Unimed Pharmaceuticals Cannabis Drug Product Overview
10.6.3 Unimed Pharmaceuticals Cannabis Drug Product Market Performance
10.6.4 Unimed Pharmaceuticals Business Overview
10.6.5 Unimed Pharmaceuticals Recent Developments
10.7 Indevus Pharmaceuticals
10.7.1 Indevus Pharmaceuticals Cannabis Drug Basic Information
10.7.2 Indevus Pharmaceuticals Cannabis Drug Product Overview
10.7.3 Indevus Pharmaceuticals Cannabis Drug Product Market Performance
10.7.4 Indevus Pharmaceuticals Business Overview
10.7.5 Indevus Pharmaceuticals Recent Developments
10.8 Pharmos
10.8.1 Pharmos Cannabis Drug Basic Information
10.8.2 Pharmos Cannabis Drug Product Overview
10.8.3 Pharmos Cannabis Drug Product Market Performance
10.8.4 Pharmos Business Overview
10.8.5 Pharmos Recent Developments
11 CANNABIS DRUG MARKET FORECAST BY REGION
11.1 Global Cannabis Drug Market Size Forecast
11.2 Global Cannabis Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cannabis Drug Market Size Forecast by Country
11.2.3 Asia Pacific Cannabis Drug Market Size Forecast by Region
11.2.4 South America Cannabis Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Cannabis Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Cannabis Drug Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Cannabis Drug by Type (2025-2032)
12.1.2 Global Cannabis Drug Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Cannabis Drug by Type (2025-2032)
12.2 Global Cannabis Drug Market Forecast by Application (2025-2032)
12.2.1 Global Cannabis Drug Sales (K Units) Forecast by Application
12.2.2 Global Cannabis Drug Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Cannabis Drug
1.2 Key Market Segments
1.2.1 Cannabis Drug Segment by Type
1.2.2 Cannabis Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CANNABIS DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cannabis Drug Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Cannabis Drug Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
2.4 Macroeconomic Analysis
3 CANNABIS DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Cannabis Drug Sales by Manufacturers (2019-2024)
3.2 Global Cannabis Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Cannabis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cannabis Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cannabis Drug Sales Sites, Area Served, Product Type
3.6 Cannabis Drug Market Competitive Situation and Trends
3.6.1 Cannabis Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cannabis Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CANNABIS DRUG INDUSTRY CHAIN ANALYSIS
4.1 Cannabis Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CANNABIS DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CANNABIS DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cannabis Drug Sales Market Share by Type (2019-2024)
6.3 Global Cannabis Drug Market Size Market Share by Type (2019-2024)
6.4 Global Cannabis Drug Price by Type (2019-2024)
7 CANNABIS DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cannabis Drug Market Sales by Application (2019-2024)
7.3 Global Cannabis Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Cannabis Drug Sales Growth Rate by Application (2019-2024)
8 CANNABIS DRUG MARKET SALES BY REGION
8.1 Global Cannabis Drug Sales by Region
8.1.1 Global Cannabis Drug Sales by Region
8.1.2 Global Cannabis Drug Sales Market Share by Region
8.2 Global Cannabis Drug Market Size by Region
8.2.1 Global Cannabis Drug Market Size by Region
8.2.2 Global Cannabis Drug Market Size Market Share by Region
8.3 North America
8.3.1 North America Cannabis Drug Sales by Country
8.3.2 North America Cannabis Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Cannabis Drug Sales by Country
8.4.2 Europe Cannabis Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Russia Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Cannabis Drug Sales by Region
8.5.2 China
8.5.3 Japan
8.5.4 South Korea
8.5.5 India
8.5.6 Southeast Asia
8.6 Asia Pacific
8.6.1 Asia Pacific Cannabis Drug Market Size by Region
8.6.2 Asia Pacific Cannabis Drug Market Size by Region
8.6.3 China
8.6.4 Japan
8.6.5 South Korea
8.6.6 India
8.6.7 Southeast Asia
8.7 South America
8.7.1 South America Cannabis Drug Sales by Country
8.7.2 South America Cannabis Drug Market Size by Country
8.7.3 Brazil
8.7.4 Argentina
8.7.5 Columbia
8.8 Middle East and Africa
8.8.1 Middle East and Africa Cannabis Drug Sales by Region
8.8.2 Middle East and Africa Cannabis Drug Market Size by Region
8.8.3 Saudi Arabia
8.8.4 UAE
8.8.5 Egypt
8.8.6 Nigeria
8.8.7 South Africa
9 CANNABIS DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Cannabis Drug by Region (2019-2024)
9.2 Global Cannabis Drug Revenue Market Share by Region (2019-2024)
9.3 Global Cannabis Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Cannabis Drug Production
9.4.1 North America Cannabis Drug Production Growth Rate (2019-2024)
9.4.2 North America Cannabis Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Cannabis Drug Production
9.5.1 Europe Cannabis Drug Production Growth Rate (2019-2024)
9.5.2 Europe Cannabis Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Cannabis Drug Production (2019-2024)
9.6.1 Japan Cannabis Drug Production Growth Rate (2019-2024)
9.6.2 Japan Cannabis Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Cannabis Drug Production (2019-2024)
9.7.1 China Cannabis Drug Production Growth Rate (2019-2024)
9.7.2 China Cannabis Drug Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Greenwich Biosciences
10.1.1 Greenwich Biosciences Cannabis Drug Basic Information
10.1.2 Greenwich Biosciences Cannabis Drug Product Overview
10.1.3 Greenwich Biosciences Cannabis Drug Product Market Performance
10.1.4 Greenwich Biosciences Business Overview
10.1.5 Greenwich Biosciences Cannabis Drug SWOT Analysis
10.1.6 Greenwich Biosciences Recent Developments
10.2 Abbive
10.2.1 Abbive Cannabis Drug Basic Information
10.2.2 Abbive Cannabis Drug Product Overview
10.2.3 Abbive Cannabis Drug Product Market Performance
10.2.4 Abbive Business Overview
10.2.5 Abbive Cannabis Drug SWOT Analysis
10.2.6 Abbive Recent Developments
10.3 Insys Therapeutics
10.3.1 Insys Therapeutics Cannabis Drug Basic Information
10.3.2 Insys Therapeutics Cannabis Drug Product Overview
10.3.3 Insys Therapeutics Cannabis Drug Product Market Performance
10.3.4 Insys Therapeutics Cannabis Drug SWOT Analysis
10.3.5 Insys Therapeutics Business Overview
10.3.6 Insys Therapeutics Recent Developments
10.4 Bausch Health
10.4.1 Bausch Health Cannabis Drug Basic Information
10.4.2 Bausch Health Cannabis Drug Product Overview
10.4.3 Bausch Health Cannabis Drug Product Market Performance
10.4.4 Bausch Health Business Overview
10.4.5 Bausch Health Recent Developments
10.5 GW Pharmaceuticals
10.5.1 GW Pharmaceuticals Cannabis Drug Basic Information
10.5.2 GW Pharmaceuticals Cannabis Drug Product Overview
10.5.3 GW Pharmaceuticals Cannabis Drug Product Market Performance
10.5.4 GW Pharmaceuticals Business Overview
10.5.5 GW Pharmaceuticals Recent Developments
10.6 Unimed Pharmaceuticals
10.6.1 Unimed Pharmaceuticals Cannabis Drug Basic Information
10.6.2 Unimed Pharmaceuticals Cannabis Drug Product Overview
10.6.3 Unimed Pharmaceuticals Cannabis Drug Product Market Performance
10.6.4 Unimed Pharmaceuticals Business Overview
10.6.5 Unimed Pharmaceuticals Recent Developments
10.7 Indevus Pharmaceuticals
10.7.1 Indevus Pharmaceuticals Cannabis Drug Basic Information
10.7.2 Indevus Pharmaceuticals Cannabis Drug Product Overview
10.7.3 Indevus Pharmaceuticals Cannabis Drug Product Market Performance
10.7.4 Indevus Pharmaceuticals Business Overview
10.7.5 Indevus Pharmaceuticals Recent Developments
10.8 Pharmos
10.8.1 Pharmos Cannabis Drug Basic Information
10.8.2 Pharmos Cannabis Drug Product Overview
10.8.3 Pharmos Cannabis Drug Product Market Performance
10.8.4 Pharmos Business Overview
10.8.5 Pharmos Recent Developments
11 CANNABIS DRUG MARKET FORECAST BY REGION
11.1 Global Cannabis Drug Market Size Forecast
11.2 Global Cannabis Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cannabis Drug Market Size Forecast by Country
11.2.3 Asia Pacific Cannabis Drug Market Size Forecast by Region
11.2.4 South America Cannabis Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Cannabis Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Cannabis Drug Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Cannabis Drug by Type (2025-2032)
12.1.2 Global Cannabis Drug Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Cannabis Drug by Type (2025-2032)
12.2 Global Cannabis Drug Market Forecast by Application (2025-2032)
12.2.1 Global Cannabis Drug Sales (K Units) Forecast by Application
12.2.2 Global Cannabis Drug Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
